Quarterly report pursuant to Section 13 or 15(d)

NET LOSS PER SHARE - Schedule of Computation of Diluted Shares Outstanding (Details)

v3.23.3
NET LOSS PER SHARE - Schedule of Computation of Diluted Shares Outstanding (Details) - shares
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Common stock issued under the backstop agreement        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive securities excluded from computation of earnings per share (in shares) 9,600,031 9,600,031 9,600,031 9,600,031
Grants of unvested restricted stock units (time-vesting only)        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive securities excluded from computation of earnings per share (in shares) 7,449,932 3,840,501 6,021,748 3,468,900
Private placement warrants        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive securities excluded from computation of earnings per share (in shares) 272,779 272,779 272,779 272,779